• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MicroRNA-203 通过下调 AKT3 抑制甲状腺乳头状癌细胞的上皮-间充质转化、侵袭和迁移。

MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3.

机构信息

Department of Nuclear Medicine, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan, China.

出版信息

Cell Cycle. 2020 May;19(10):1105-1121. doi: 10.1080/15384101.2020.1746490. Epub 2020 Apr 19.

DOI:10.1080/15384101.2020.1746490
PMID:32308106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7217351/
Abstract

MicroRNAs (miRNAs) have been reported to serve pivotal roles in the regulation of papillary thyroid cancer (PTC) development; thus, the aim of this study is to identify the impact of miR-203 and AKT3 on the epithelial-mesenchymal transition (EMT), migration and invasion of PTC. MiR-203 and AKT3 expression in PTC tissues and cells were tested. TPC-1 cells and K1 cells were screened for follow-up experiments. Apoptosis-related proteins (Bcl-2 and Bax), EMT-related proteins (Vimentin and E-cadherin), proliferation-associated proteins (Ki67 and CDK4), invasion- and migration-related protein (MMP-2 and MMP-9) were verified. The effects of upregulated miR-203 and downregulated AKT3 on the biological characteristics of PTC cells in each group were detected via the gain- and loss-of-function assays. The targeting relationship between miR-203 and AKT3 was verified.MiR-203 expression declined and AKT3 heightened in PTC tissues and cells. Upregulated miR-203 and downregulated AKT3 reduced the tumor volume and weight, suppressed cell migration, colony formation, proliferation, invasion, proliferation-associated proteins (Ki67 and CDK4), invasion- and migration-related protein (MMP-2 and MMP-9) and promoted cell apoptosis, raised E-cadherin and decreased Vimentin protein expression in TPC-1 cells. On the contrary, the K1 cells with the downregulated miR-203 or upregulated AKT3 exhibited an opposite result. This study suggests that upregulated miR-203 suppresses EMT, invasion, proliferation and migration as well as induces apoptosis of PTC cells via downregulated AKT3.

摘要

微小 RNA(miRNAs)已被报道在调控甲状腺乳头状癌(PTC)发展中起关键作用;因此,本研究旨在确定 miR-203 和 AKT3 对 PTC 上皮-间充质转化(EMT)、迁移和侵袭的影响。检测了 PTC 组织和细胞中的 miR-203 和 AKT3 表达。筛选 TPC-1 细胞和 K1 细胞进行后续实验。验证了凋亡相关蛋白(Bcl-2 和 Bax)、EMT 相关蛋白(波形蛋白和 E-钙黏蛋白)、增殖相关蛋白(Ki67 和 CDK4)、侵袭和迁移相关蛋白(MMP-2 和 MMP-9)。通过功能获得和缺失实验检测了上调 miR-203 和下调 AKT3 对各组 PTC 细胞生物学特性的影响。验证了 miR-203 和 AKT3 之间的靶向关系。miR-203 在 PTC 组织和细胞中的表达降低,AKT3 表达升高。上调 miR-203 和下调 AKT3 降低了肿瘤体积和重量,抑制了细胞迁移、集落形成、增殖、侵袭、增殖相关蛋白(Ki67 和 CDK4)、侵袭和迁移相关蛋白(MMP-2 和 MMP-9),促进了细胞凋亡,提高了 TPC-1 细胞中 E-钙黏蛋白的表达,降低了波形蛋白的表达。相反,下调 miR-203 或上调 AKT3 的 K1 细胞则表现出相反的结果。本研究表明,上调的 miR-203 通过下调 AKT3 抑制 PTC 细胞的 EMT、侵袭、增殖和迁移,并诱导其凋亡。

相似文献

1
MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3.MicroRNA-203 通过下调 AKT3 抑制甲状腺乳头状癌细胞的上皮-间充质转化、侵袭和迁移。
Cell Cycle. 2020 May;19(10):1105-1121. doi: 10.1080/15384101.2020.1746490. Epub 2020 Apr 19.
2
LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis.LncRNA-HCG18 通过调控 miR-106a-5p/PPP2R2A 轴调节甲状腺乳头状癌细胞的活力、凋亡、迁移、侵袭和上皮间质转化。
Pathol Res Pract. 2021 May;221:153395. doi: 10.1016/j.prp.2021.153395. Epub 2021 Mar 4.
3
MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.miR-520a-3p 通过 JAK1 介导的 JAK/STAT 信号通路抑制甲状腺乳头状癌细胞的上皮-间充质转化、侵袭和迁移。
J Cell Physiol. 2019 Apr;234(4):4054-4067. doi: 10.1002/jcp.27199. Epub 2018 Sep 12.
4
miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.miR-215 通过靶向 ARFGEF1 抑制 AKT/GSK-3β/Snail 信号通路抑制甲状腺乳头状癌细胞的增殖、迁移和侵袭。
Cell Death Dis. 2019 Feb 27;10(3):195. doi: 10.1038/s41419-019-1444-1.
5
microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway.miRNA-599 通过下调 Hey2 依赖性 Notch 信号通路促进甲状腺乳头状癌细胞凋亡,抑制增殖和上皮间质转化。
J Cell Physiol. 2020 Mar;235(3):2492-2505. doi: 10.1002/jcp.29154. Epub 2019 Sep 29.
6
microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.microRNA-539 通过靶向分泌白细胞蛋白酶抑制剂在甲状腺乳头状癌中作为肿瘤抑制因子通过转化生长因子β1/Smads 信号通路发挥作用。
J Cell Biochem. 2019 Jun;120(6):10830-10846. doi: 10.1002/jcb.28374. Epub 2019 Jan 31.
7
Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.长链非编码 RNA SNHG22 通过与 microRNA-429 竞争结合增加 ZEB1 表达,促进甲状腺乳头状癌的恶性发展。
Cell Cycle. 2020 May;19(10):1186-1199. doi: 10.1080/15384101.2020.1749466. Epub 2020 Apr 19.
8
MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.MicroRNA-31 通过直接靶向 SOX11 并调节上皮间质转化、ERK 和 Akt 信号通路抑制甲状腺乳头状癌细胞的生物学进展。
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5863-5873. doi: 10.26355/eurrev_201907_18329.
9
MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.微小 RNA-486 通过下调 TENM1 的表达,影响 ERK 和 Akt 信号通路以及甲状腺乳头状癌的上皮间质转化,抑制细胞增殖、侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8429-8439. doi: 10.26355/eurrev_201910_19155.
10
MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.微小 RNA-1271 通过靶向 IRS1 并使 AKT 通路失活抑制甲状腺乳头状癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7989-7999. doi: 10.26355/eurrev_201909_19015.

引用本文的文献

1
The regulatory network of epithelial-mesenchymal transition-associated non-coding RNAs in thyroid cancer: molecular mechanisms, clinical implications, and therapeutic strategies.甲状腺癌中上皮-间质转化相关非编码RNA的调控网络:分子机制、临床意义及治疗策略
Front Oncol. 2025 Jun 2;15:1592467. doi: 10.3389/fonc.2025.1592467. eCollection 2025.
2
The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma.MMP-9 及其抑制剂在不同类型甲状腺癌中的作用。
Molecules. 2023 Apr 25;28(9):3705. doi: 10.3390/molecules28093705.
3
Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer.用于甲状腺乳头状癌诊断和预后的微小RNA差异表达
Front Med (Lausanne). 2023 Apr 5;10:1139362. doi: 10.3389/fmed.2023.1139362. eCollection 2023.
4
The role of miR-139-5p in radioiodine-resistant thyroid cancer.miR-139-5p 在碘难治性甲状腺癌中的作用。
J Endocrinol Invest. 2023 Oct;46(10):2079-2093. doi: 10.1007/s40618-023-02059-7. Epub 2023 Mar 18.
5
Hsa_circ_0000520 Promotes Non-Small Cell Lung Cancer Progression through the miR-1258/AKT3 Axis.Hsa_circ_0000520通过miR-1258/AKT3轴促进非小细胞肺癌进展。
J Oncol. 2022 Dec 24;2022:3676685. doi: 10.1155/2022/3676685. eCollection 2022.
6
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.微小RNA作为甲状腺癌中细胞迁移和侵袭的关键调节因子。
Biomark Res. 2022 Jun 4;10(1):40. doi: 10.1186/s40364-022-00382-4.
7
MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy.微小 RNA-203a-3p 可能通过抑制 MAP3K1 和激活自噬来预防甲状腺乳头状癌的发展。
J Clin Lab Anal. 2022 Jun;36(6):e24470. doi: 10.1002/jcla.24470. Epub 2022 May 6.
8
LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway.富含亮氨酸重复序列蛋白 1(LEMD1)转录激活因子 SRY 相关高迁移率族盒蛋白 4(SOX4)通过上调磷脂酰肌醇 3-激酶(PI3K)/蛋白激酶 B(Akt)信号通路加速结肠癌细胞的进展。
Bioengineered. 2022 Apr;13(4):8087-8100. doi: 10.1080/21655979.2022.2047556.
9
E-cadherin on epithelial-mesenchymal transition in thyroid cancer.E-钙黏蛋白与甲状腺癌上皮-间质转化的关系
Cancer Cell Int. 2021 Dec 20;21(1):695. doi: 10.1186/s12935-021-02344-6.
10
NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial-Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3.NR2F1-AS1/miR-190a/PHLDB2通过促进AKT3磷酸化诱导胃癌上皮-间质转化过程
Front Cell Dev Biol. 2021 Oct 22;9:688949. doi: 10.3389/fcell.2021.688949. eCollection 2021.

本文引用的文献

1
Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K/Akt signaling pathway via PIK3CA.miR-203 通过抑制 PIK3CA 对 PI3K/Akt 信号通路的抑制作用,上调抑制糖尿病心肌病小鼠心肌纤维化和氧化应激。
Gene. 2019 Oct 5;715:143995. doi: 10.1016/j.gene.2019.143995. Epub 2019 Jul 20.
2
A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.一种新的长链非编码 RNA n384546 通过作为 miR-145-5p 的竞争性内源性 RNA 来调节 AKT3,促进甲状腺乳头状癌的进展和转移。
Cell Death Dis. 2019 Jun 3;10(6):433. doi: 10.1038/s41419-019-1637-7.
3
Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients.循环 miR-203 来源于转移组织促进结直肠癌患者的肌肉减少症。
J Cachexia Sarcopenia Muscle. 2019 Jun;10(3):536-548. doi: 10.1002/jcsm.12403. Epub 2019 Mar 25.
4
LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.长链非编码 RNA MCM3AP-AS1 通过调控 miR-211-5p/SPARC 轴促进甲状腺乳头状癌细胞的增殖和侵袭。
Endocrine. 2019 Aug;65(2):318-326. doi: 10.1007/s12020-019-01939-4. Epub 2019 Apr 27.
5
Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.甲状腺乳头状癌跳跃性转移和侧颈部淋巴结转移的危险因素。
Surgery. 2019 Jul;166(1):55-60. doi: 10.1016/j.surg.2019.01.025. Epub 2019 Mar 12.
6
CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.环状 RNA circRNA_102171 通过调节 CTNNBIP1 依赖性 β-连环蛋白通路的激活促进甲状腺乳头状癌的进展。
J Exp Clin Cancer Res. 2018 Nov 13;37(1):275. doi: 10.1186/s13046-018-0936-7.
7
Ultrasound features of extranodal extension in the metastatic cervical lymph nodes of papillary thyroid cancer: a case-control study.甲状腺乳头状癌颈部转移性淋巴结结外侵犯的超声特征:一项病例对照研究
Cancer Biol Med. 2018 May;15(2):171-177. doi: 10.20892/j.issn.2095-3941.2017.0092.
8
MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.微小 RNA-222 通过靶向蛋白磷酸酶 2 调节亚基 Bα表达促进甲状腺乳头状癌的侵袭和转移。
Thyroid. 2018 Sep;28(9):1162-1173. doi: 10.1089/thy.2017.0665. Epub 2018 Aug 21.
9
The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.miR-203/SNAI2 轴通过调节 GSK-3β/β-CATENIN 信号通路,潜在地调节前列腺肿瘤的生长、迁移、血管生成和干性。
IUBMB Life. 2018 Mar;70(3):224-236. doi: 10.1002/iub.1720. Epub 2018 Feb 1.
10
The expression level of miR-203 in patients with gastric cancer and its clinical significance.miR-203在胃癌患者中的表达水平及其临床意义。
Pathol Res Pract. 2017 Dec;213(12):1515-1518. doi: 10.1016/j.prp.2017.09.025. Epub 2017 Sep 28.